Agilent introduced a multimode real-time cell analyzer combining non-invasive biosensor measurement with live cell imaging.

"The xCELLigence RTCA eSight will revolutionize cell analysis in life science research," said Todd Christian, Agilent vice president, and general manager of the company’s Cell Analysis Division. "Cells are continuously monitored through biosensors and imaging at predefined temporal resolutions for days or weeks, in a well-controlled, physiologically relevant environment. With one experiment, scientists can now get two vantage points into cell health and their responses to a variety of chemical or biological manipulations, giving them greater confidence in the data they collect."

The new instrument builds on the xCELLigence biosensor technology, which Agilent obtained through its acquisition of ACEA Biosciences late last year.

"The xCELLigence RTCA eSight represents the frontier of cell analysis technology by providing unparalleled information with deep biological insights into cellular function," said Xiaobo Wang, Ph.D., who joined Agilent from ACEA, as general manager of the Flow Cytometry and Real-Time Cell Analysis Business. "The eSight is the latest addition to Agilent’s cell analysis portfolio, exemplifying our commitment to popularizing live cell, kinetic analysis in applications across a wide spectrum of research areas including cell biology, immunology, immuno-oncology, and immunotherapy."

The system offers:

Provides label-free, real-time biosensor measurements, and kinetic imaging of the same live cell populations, independently, or simultaneously.

Monitors cell health, adhesion, morphology, proliferation, and cytolysis in primary or native cells alone or in co-culture providing unprecedented insight into cellular mechanisms and functionality.

Supports three fluorescence channels, a variety well-plate formats, an array of reporter reagents, and flexible user-defined schedules.

Reads a 96-well plate in 15 seconds.

This product is for research use only. Not for use in diagnostic procedures.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com